AAV9‐mediated AIRE gene delivery clears circulating antibodies and tissue T‐cell infiltration in a mouse model of autoimmune polyglandular syndrome type‐1
Abstract Objectives Autoimmune polyglandular syndrome type‐1 (APS‐1) is a monogenic recessive disorder characterised by multiple endocrine abnormalities, chronic mucocutaneous candidiasis and high titres of serum autoantibodies. To date, no curative treatment is available; current therapies manage t...
Main Authors: | Sarah Almaghrabi, Mimoun Azzouz, Rachid Tazi Ahnini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1166 |
Similar Items
-
Autoimmune polyglandular syndrome type II in Hospital Universitario del Caribe, Cartagena Colombia.
by: Fortich-Revollo Álvaro José, et al.
Published: (2011-06-01) -
Autoimmune Polyglandular Syndrome Type 2 and Pregnancy
by: Vesselina Yanachkova, et al.
Published: (2020-06-01) -
Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes
by: Elena N. Savvateeva, et al.
Published: (2021-05-01) -
Highly raised serum lipid levels in a child with autoimmune polyglandular syndrome type III A: A novel experience
by: Sourav Das Choudhury, et al.
Published: (2015-01-01) -
Achalasia in a Patient with Polyglandular Autoimmune Syndrome Type II
by: Bashar S. Amr, et al.
Published: (2015-05-01)